Device runtime and costs of cardiac resynchronization therapy pacemakers - a health claims data analysis

Moritz Hadwiger, Nikolaos Dagres, Gerhard Hindricks, Helmut L'hoest, Ursula Marschall, Alexander Katalinic, Fabian-Simon Frielitz


Introduction: This study investigates the runtime and costs of biventricular defibrillators (CRT-D) and biventricular pacemakers (CRT-P). Accurate estimates of cardiac resynchronization therapy (CRT) device runtime across all manufactures are rare, especially for CRT-P. Methods: Health claims data of a large nationwide German health insurance was used to analyze CRT device runtime. We defined device runtime as the time between the date of implantation and the date of generator change or removal. The median costs for implantation, change, and removal of a CRT device were calculated accordingly. Results: In total, the data set comprises 17,826 patients. A total of 4,296 complete runtimes for CRT-D devices and 429 complete runtimes for CRT-P devices were observed. Median device runtime was 6.04 years for CRT-D devices and 8.16 years for CRT-P devices (log-rank test p<0.0001). The median cost of implantation for a CRT-D device was 14,270 EUR, and for a CRT-P device 9,349 EUR. Conclusions: Compared to CRT-P devices, CRT-D devices had a significantly shorter device runtime of about two years. Moreover, CRT-D devices were associated with higher cost. The study provides important findings that can be utilized by cost-effectiveness analyses.

Original languageGerman
Article numberDoc02
JournalGerman medical science : GMS e-journal
Pages (from-to)Doc02
Publication statusPublished - 2022

Research Areas and Centers

  • Research Area: Center for Population Medicine and Public Health (ZBV)


Dive into the research topics of 'Device runtime and costs of cardiac resynchronization therapy pacemakers - a health claims data analysis'. Together they form a unique fingerprint.

Cite this